N-乙半氨酸对肝脏,血液和病患者肝脏参数的影响:一项随机对照试验
Behzad Hatami1, Saeed Abdi2, Mohamad Amin Pourhoseingholi1
1Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Teheran, Iran.
Gastroenterology and hepatology from bed to bench
|February 5, 2024
概括
补充N-乙半氨酸 (NAC) 改善了肝硬化患者的肝脏和脏功能,通过减少肝脏酶和改善得分. NAC并没有显著影响血液学或生物化学参数.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性肝炎通过氧化应激驱动纤维化和肝硬化.
- N-乙半氨酸 (NAC) 是一种能中和活性氧物种的谷氨前体.
- 以前的研究表明,NAC在预防肝损伤方面有好处,但需要更多的人类数据.
研究的目的:
- 评估N-乙半氨酸 (NAC) 补充对肝硬化患者的影响.
- 评估NAC对肝功能,功能和疾病严重程度得分的影响.
主要方法:
- 一个随机,双盲,安慰剂对照试验,涉及60名肝硬化患者 (年龄18-70岁).
- 干预组每天接受600毫克NAC;对照组接受安慰剂6个月.
- 在基线和6个月后评估人口统计数据,医疗特征,Child-Pugh和MELD得分.
主要成果:
- 补充NAC显著降低血清尿素和肌素,表明功能得到改善.
- 肝脏参数,包括ALT,AST和ALP,在NAC组显著下降.
- 在接受NAC的患者中,Child-Pugh和MELD得分显著降低.
结论:
- 补充N-乙半氨酸 (NAC) 在肝硬化患者的肝脏和功能改善方面表现出有效性.
- NAC有效地降低了肝酶和疾病严重程度得分 (查尔德-普和MELD).
- 没有观察到NAC对血液学和一般生化参数的显著影响.
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
210
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
210
Phase II Reactions: Acetylation Reactions
228
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
228
Factors Affecting Renal Clearance: Renal Impairment
95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
92
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Anticholinesterase Agents: Poisoning and Treatment
859
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
859


